These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4476752)

  • 21. Inclusion complexes of beta-cyclodextrin with tranquilizing drugs phenothiazines in aqueous solution.
    Otagiri M; Uekama K; Ikeda K
    Chem Pharm Bull (Tokyo); 1975 Jan; 23(1):188-95. PubMed ID: 240508
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of roll mixing with beta-cyclodextrin on enhancing solubilities of water insoluble drugs.
    Nozawa Y; Yamamoto A
    Pharm Acta Helv; 1989; 64(1):24-9. PubMed ID: 2717647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of alpha- or beta-cyclodextrin on gastrointestinal absorption of barbituric acid derivatives (author's transl)].
    Koizumi K; Kidera Y
    Yakugaku Zasshi; 1977 Jul; 97(7):705-11. PubMed ID: 915696
    [No Abstract]   [Full Text] [Related]  

  • 24. [Dissolution profiles of powdered inclusion compounds of sulfonamide drugs with beta-cyclodextrin].
    Chen JY; Tsai WY
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1989 Apr; 5(4):206-11. PubMed ID: 2769826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvements in self-curing composites.
    Raszewski Z; Jałbrzykowski M
    Adv Med Sci; 2017 Sep; 62(2):398-404. PubMed ID: 28618330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Solubility behavior of barbituric acids in aqueous solution of sodium alkyl sulfonate as a function of concentration and temperature.
    Vaution C; Treiner C; Puisieux F; Carstensen JT
    J Pharm Sci; 1981 Nov; 70(11):1238-42. PubMed ID: 6271945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of cyclodextrins with fluorescent probes and its application to kinetic studies of amylase.
    Kondo H; Nakatani H; Hiromi K
    J Biochem; 1976 Feb; 79(2):393-405. PubMed ID: 5431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poly-(cyclo)dextrins as ethoxzolamide carriers in ophthalmic solutions and in contact lenses.
    García-Fernández MJ; Tabary N; Martel B; Cazaux F; Oliva A; Taboada P; Concheiro A; Alvarez-Lorenzo C
    Carbohydr Polym; 2013 Nov; 98(2):1343-52. PubMed ID: 24053812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The in vitro availability of some barbituric acid derivatives and its correlation to solubility parameter.
    Khalil SA; Abdallah OY; Moustafa MA
    Pharm Acta Helv; 1983; 58(11):307-13. PubMed ID: 6647493
    [No Abstract]   [Full Text] [Related]  

  • 30. Cyclodextrin nephrosis in the rat.
    Frank DW; Gray JE; Weaver RN
    Am J Pathol; 1976 May; 83(2):367-82. PubMed ID: 1266946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utilization of diethyl-beta-cyclodextrin as a sustained-release carrier for isosorbide dinitrate.
    Hirayama F; Hirashima N; Abe K; Uekama K; Ijitsu T; Ueno M
    J Pharm Sci; 1988 Mar; 77(3):233-6. PubMed ID: 3373427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and investigation of hydrochlorothiazide products containing beta-cyclodextrin.
    Kata M; Lukács M
    Pharmazie; 1984 Dec; 39(12):857-8. PubMed ID: 6531397
    [No Abstract]   [Full Text] [Related]  

  • 33. INTERACTION OF PHARMACEUTICALS WITH SCHARDINGER DEXTRINS. III. INTERACTIONS WITH MONO-HALOGENATED BENZOIC ACIDS AND AMINOBENZOIC ACIDS.
    LACH JL; CHIN TF
    J Pharm Sci; 1964 Jan; 53():69-73. PubMed ID: 14106377
    [No Abstract]   [Full Text] [Related]  

  • 34. Investigation of the beta-cyclodextrin-hydrocortisone inclusion compound.
    Frank SG; Kavaliunas DR
    J Pharm Sci; 1983 Oct; 72(10):1215-7. PubMed ID: 6644576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FORMATION AND DEGRADATION OF CYCLIC DEXTRINS BY INTRACELLULAR ENZYMES OF BACILLUS MACERANS.
    DEPINTO JA; CAMPBELL LL
    Science; 1964 Nov; 146(3647):1064-6. PubMed ID: 14202462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wettability of cyclodextrin complexes.
    Szente L; Szejtli J
    Acta Pharm Hung; 1987 Mar; 57(1-2):73-6. PubMed ID: 3591344
    [No Abstract]   [Full Text] [Related]  

  • 37. Phase solubility analysis and PMR study of complexing behavior of dinoprostone with beta-cyclodextrin in water.
    Frank SG; Cho MJ
    J Pharm Sci; 1978 Dec; 67(12):1665-8. PubMed ID: 722476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of stability and biological effect on cholecalciferol by beta-cyclodextrin complexation.
    Szejtli J; Bolla-Pusztai E; Szabó P; Ferenczy T
    Pharmazie; 1980 Dec; 35(12):779-87. PubMed ID: 6259671
    [No Abstract]   [Full Text] [Related]  

  • 39. Suppositories containing cyclodextrin complexes. Part 2: Dissolution and absorption studies.
    Szente L; Apostol I; Gerlóczy A; Szejtli J
    Pharmazie; 1985 Jun; 40(6):406-7. PubMed ID: 4034649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of solubility of furosemide with beta-cyclodextrin.
    Kata M; Antal A
    Pharmazie; 1984 Dec; 39(12):856-7. PubMed ID: 6531396
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.